Silvestri Elena, Lombardi Assunta, de Lange Pieter, Glinni Daniela, Senese Rosalba, Cioffi Federica, Lanni Antonia, Goglia Fernando, Moreno Maria
Dipartimento di Scienze Biologiche ed Ambientali, Università degli Studi del Sannio, Via Port'Arsa 11, 82100 Benevento, Italy.
J Biomed Biotechnol. 2011;2011:810242. doi: 10.1155/2011/810242. Epub 2010 Oct 11.
Omics approaches to the study of complex biological systems with potential applications to molecular medicine are attracting great interest in clinical as well as in basic biological research. Genomics, transcriptomics and proteomics are characterized by the lack of an a priori definition of scope, and this gives sufficient leeway for investigators (a) to discern all at once a globally altered pattern of gene/protein expression and (b) to examine the complex interactions that regulate entire biological processes. Two popular platforms in "omics" are DNA microarrays, which measure messenger RNA transcript levels, and proteomic analyses, which identify and quantify proteins. Because of their intrinsic strengths and weaknesses, no single approach can fully unravel the complexities of fundamental biological events. However, an appropriate combination of different tools could lead to integrative analyses that would furnish new insights not accessible through one-dimensional datasets. In this review, we will outline some of the challenges associated with integrative analyses relating to the changes in metabolic pathways that occur in complex pathophysiological conditions (viz. ageing and altered thyroid state) in relevant metabolically active tissues. In addition, we discuss several new applications of proteomic analysis to the investigation of mitochondrial activity.
用于研究复杂生物系统并可能应用于分子医学的组学方法,在临床以及基础生物学研究中都引起了极大的兴趣。基因组学、转录组学和蛋白质组学的特点是缺乏对研究范围的先验定义,这为研究人员提供了足够的空间:(a)一次性识别基因/蛋白质表达的全局改变模式;(b)研究调节整个生物过程的复杂相互作用。“组学”中有两个流行的平台,即测量信使核糖核酸转录水平的DNA微阵列和识别并定量蛋白质的蛋白质组学分析。由于它们各自的优缺点,没有一种单一方法能够完全揭示基本生物事件的复杂性。然而,不同工具的适当组合可能会导致综合分析,从而提供通过一维数据集无法获得的新见解。在这篇综述中,我们将概述与综合分析相关的一些挑战,这些挑战涉及在相关代谢活跃组织中复杂病理生理状况(即衰老和甲状腺状态改变)下发生的代谢途径变化。此外,我们还讨论了蛋白质组学分析在研究线粒体活性方面的几个新应用。